In response to a new study suggesting researchers at Orlucent, Inc. have demonstrated the viability of a novel handheld point-of-care molecular Skin Fluorescence Imaging System to noninvasively identify and clinically assess the presence of biological tissue remodeling activity associated with the development of melanoma in adults, Sancy Leachman, M.D., Ph.D., says: “I am particularly excited about the ability … to assess aspects of stromal tissue remodeling that are invisible to the human eye clinically through direct examination or traditional pathological examination of nevi, enabling the categorization of lesions of concern more accurately at a very early stage at the point of care.”

Axios Portland reports on the outlook for COVID-19, influenza and RSV in Oregon. Peter Graven, Ph.D., says, “Despite quite a few more people getting it, and certainly more hospitalizations, it’s not going to have the kind of impact that we had during the delta wave.”

New Scientist reports that scientists in China have cloned a healthy rhesus monkey. Shoukhrat Mitalipov, Ph.D., says cloning methods at OHSU aim to treat disease at the molecular level: “In our case, we hope that someday doctors will be able to use rejection-proof, genetically matched embryonic stem cells to replace diseased nerve, muscle, blood and other cells, or to produce eggs to treat infertility.”

New OHSU research for the first time reveals the function of a little-understood synapse between cells in the brain in live tissue. Kelly Monk, Ph.D., says, “This gives an understanding of the basic, fundamental properties of how these cells work in normal development. In the future, we might look at how they function differently in the context of MS patients.”

The La Grande Observer reports that the Union County Sheriff’s Office will begin providing access to medication for treating inmates with opioid use disorder, noting that it is contracting with Dan Hoover, M.D., to do so.

The newly formed OHSU Knight Cancer Precision Biofabrication Hub — designed to take small samples of human cells from organ tissues to reproduce organs, cancerous tumors, and bone material using 3D bioprinters and other advanced engineering, opening new avenues for understanding and treating cancer — is included in a 3-D Printing.com round-up of the top “Bioprinting’s Investment Milestones of 2023.” Director Luiz Bertassoni, Ph.D., D.D.S., says: “The mission of the Cancer Institute is to end cancer as we know it.”

New OHSU research for the first time reveals the function of a little-understood synapse between cells in the brain in live tissue. Kelly Monk, Ph.D., says, “This gives an understanding of the basic, fundamental properties of how these cells work in normal development. In the future, we might look at how they function differently in the context of MS patients.”

POLITICO is among news outlets to cover a new OHSU-led study that found residential addiction treatment for adolescents to be costly and scarce nationwide.

Thirty new medical laboratory science professionals are entering the region’s workforce after completing a rigorous bachelor’s degree program at Oregon Tech and OHSU.

Eric Simpson, M.D., is quoted in a Dermatology Times story and other outlets about positive efficacy and safety data for tapinarof cream to treat atopic dermatitis in patients 2 years old and older.